Ascendis Pharma A/S Competitors, Revenue, Alternatives and Pricing

Claim your profile


Hellerup, Denmark
Total Funding:$168M
Lead Investor(s):J.P. Morgan Securities LLC,

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Ascendis Pharma A/S's estimated annual revenue is currently $78.7M per year.(?)
  • Ascendis Pharma A/S received $115.0M in venture funding in October 2016.
  • Ascendis Pharma A/S's estimated revenue per employee is $155,000
  • Ascendis Pharma A/S's total funding is $168M.

Employee Data

  • Ascendis Pharma A/S has 508 Employees.(?)
  • Ascendis Pharma A/S grew their employee count by 48% last year.
  • Ascendis Pharma A/S currently has 1 job openings.

Ascendis Pharma is a biotechnology company applying its innovative prodrug technology to build a leading, fully integrated rare disease company. Our science-driven and passionate people are advancing a pipeline of endocrinology programs focused on making a difference in patients lives. By utilizing our TransCon technology with clinically validated parent drugs, we create new therapies with potential for best-in-class efficacy, safety and/or convenience. Ascendis Pharma is headquartered in Copenhagen, Denmark, maintains an office in Palo Alto, California, and has research and development facilities in Heidelberg, Germany, and Copenhagen, Denmark.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power